The immunotherapeutic approach for the treatment of cancer, while in the early stages of development, is identified as a promising tool for fighting this disease. In order to improve the immunotherapy, it is necessary to understand how the immune system interacts with cancer cells and how to induce a strong immune response.
In it’s 2nd year, this conference provides you with the latest strategies for designing immunotherapeutic based cancer treatments. Gain important insights in cancer vaccine research as leading experts discuss their findings on:

• Dendritic Cell Based Immunotherapies
• Ongoing Clinical Trials
• Novel Immune Enhancers
• Immune Monintoring

Furthermore, various approaches to designing cancer vaccines will be presented such as: Peptide Based Vaccines, Carcinoembryonic Based Antigen, Fully Human Antibodies, Inducing CD8+ T cells, Heat Shock Proteins and Telomerase Reverse Transcriptase.

Don’t miss this opportunity to discuss the latest discoveries within this ever changing area of science. REGISTER EARLY - SPACE IS LIMITED!

New This Year!

Pre-Conference Workshop: Wednesday, April 23, 2002
Cancer Vaccines - from the Bench to the Marketplace

Detailed Agenda and online registration available at website.